Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details)

v3.21.2
Note 8 - Supplemental Equity and Accumulated Other Comprehensive Income (Loss) - Changes in Accumulated Other Comprehensive Income (Loss), Net of Tax (Details) - USD ($)
$ in Thousands
 3 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Balance $ 1,562,971  
Balance 1,639,365  
AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-sale, Parent [Member]    
Balance (6,193) $ (13,253)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne 84 11
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 1,598 [1] 2,132 [2]
Balance (4,511) [3] (11,110)
Accumulated Foreign Currency Adjustment Attributable to Parent [Member]    
Balance (51,098) (83,946)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (8,607) 11,914
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 0 [1] 0 [2]
Balance (59,705) [3] (72,032)
AOCI Attributable to Parent [Member]    
Balance (57,291) (97,199)
Other comprehensive income (loss) before reclassifications, net of taxes, attributable to Bio-Techne (8,523) 11,925
Reclassification from loss on derivatives to interest expense, net of taxes, attributable to Bio-Techne(1) 1,598 [1] 2,132 [2]
Balance $ (64,216) [3] $ (83,142)
[1] Gains (losses) on the interest swap are reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified ($2,091) to interest expense and a related tax benefit of $493 during the quarter ended September 30, 2021.
[2] Gains (losses) on the interest swap are reclassified into interest expense as payments on the derivative agreement are made. The Company reclassified ($2,769) to interest expense and a related tax benefit of $637 during the quarter ended September 30, 2020.
[3] The Company had net deferred tax benefits of $1,391 and $3,413 included in the accumulated other comprehensive income loss as of September 30, 2021 and 2020, respectively.